Inspecs Group PLC
LSE:SPEC

Watchlist Manager
Inspecs Group PLC Logo
Inspecs Group PLC
LSE:SPEC
Watchlist
Price: 40 GBX -3.61% Market Closed
Market Cap: 40.7m GBX
Have any thoughts about
Inspecs Group PLC?
Write Note
Section:
 

Relative Value

The Relative Value of one SPEC stock under the Base Case scenario is 256.09 GBX. Compared to the current market price of 40 GBX, Inspecs Group PLC is Undervalued by 84%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SPEC Relative Value
Base Case
256.09 GBX
Undervaluation 84%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
49
vs Industry
86
Median 3Y
0.4
Median 5Y
0.3
Industry
2.3
Forward
0.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-48.4
Median 5Y
-69.2
Industry
23
Forward
4.8
More Details
3
P/OCF
P/OCF
Price to OCF
3
vs History
57
vs Industry
47
Median 3Y
11.6
Median 5Y
6.7
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
39
Median 3Y
-5.9
Median 5Y
-7.3
Industry
20
More Details
0.4
P/B
P/B
Price to Book Value
0.4
vs History
76
vs Industry
75
Median 3Y
0.8
Median 5Y
1.7
Industry
2.2
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
50
vs Industry
80
Median 3Y
0.5
Median 5Y
0.4
Industry
2.4
Forward
0.2
More Details
0.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.6
vs History
52
vs Industry
82
Median 3Y
1
Median 5Y
0.8
Industry
5
More Details
4.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
4.4
vs History
49
vs Industry
45
Median 3Y
7.8
Median 5Y
5.6
Industry
12.9
Forward
2.5
More Details
38.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
38.5
vs History
27
vs Industry
14
Median 3Y
41.5
Median 5Y
29.4
Industry
17.4
Forward
8.2
More Details
4.7
EV/OCF
EV/OCF
Enterprise Value to OCF
4.7
vs History
59
vs Industry
44
Median 3Y
15.2
Median 5Y
9
Industry
14
More Details
8.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
8.7
vs History
59
vs Industry
30
Median 3Y
32.4
Median 5Y
16.6
Industry
18.2
More Details
0.4
EV/IC
EV/IC
Enterprise Value to IC
0.4
vs History
77
vs Industry
77
Median 3Y
0.6
Median 5Y
1.1
Industry
1.9
More Details

Multiples Across Competitors

SPEC Competitors Multiples
Inspecs Group PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Inspecs Group PLC
LSE:SPEC
40.7m GBP 0.2 -9.9 4.4 38.5
JP
Hoya Corp
TSE:7741
7.1T JPY 8.6 36.2 23.9 28.8
CH
Alcon AG
SIX:ALC
37.7B CHF 4.2 35.7 17.5 33.9
DK
Coloplast A/S
CSE:COLO B
177.1B DKK 6.6 35.4 22.6 26.6
US
Align Technology Inc
NASDAQ:ALGN
16.1B USD 4.1 36.4 18.4 22.1
KR
HLB Inc
KOSDAQ:028300
10.5T KRW 201.6 -56.4 -86.8 -81.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51.1B CNY 11.5 27.6 24 24
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD 4.4 15.3 10.6 12
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD 1.4 -17.3 16.8 56.1
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 37.2 264.5 462
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.3 47.6 23.2 38.1
P/E Multiple
Earnings Growth PEG
UK
Inspecs Group PLC
LSE:SPEC
Average P/E: 33.9
Negative Multiple: -9.9 		N/A N/A
JP
Hoya Corp
TSE:7741
36.2
15%
2.4
CH
Alcon AG
SIX:ALC
35.7
27%
1.3
DK
Coloplast A/S
CSE:COLO B
35.4
15%
2.4
US
Align Technology Inc
NASDAQ:ALGN
36.4
26%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -56.4 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.6
24%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.3
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.3 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
37.2
46%
0.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
47.6
37%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Inspecs Group PLC
LSE:SPEC
Average EV/EBITDA: 42.6
4.4
19%
0.2
JP
Hoya Corp
TSE:7741
23.9
15%
1.6
CH
Alcon AG
SIX:ALC
17.5
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.6
11%
2.1
US
Align Technology Inc
NASDAQ:ALGN
18.4
15%
1.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -86.8 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24
27%
0.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.6
11%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.8
22%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
264.5
12%
22
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.2
22%
1.1

See Also

Summary
SPEC intrinsic value, competitors valuation, and company profile.
DCF Valuation
SPEC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SPEC stock valuation using valuation multiples.
Wall Street Estimates
SPEC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SPEC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 215,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.